Literature DB >> 7444853

Thromboxane production and platelet aggregation in diabetic subjects with clinical complications.

A Butkus, V A Skrinska, O P Schumacher.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7444853     DOI: 10.1016/0049-3848(80)90420-x

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  8 in total

Review 1.  Endothelial function. General considerations.

Authors:  H Haller
Journal:  Drugs       Date:  1997       Impact factor: 9.546

2.  Absence of effect of dipyridamole on renal and platelet function in diabetes mellitus.

Authors:  D M Gibb; D Dunger; M Levin; D Grant; P Jones; T M Barratt
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

3.  Kawasaki syndrome.

Authors:  J Price
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-28

4.  Increased platelet thromboxane receptor sensitivity in diabetic patients with proliferative retinopathy.

Authors:  A Collier; P Tymkewycz; R Armstrong; R J Young; R L Jones; B F Clarke
Journal:  Diabetologia       Date:  1986-08       Impact factor: 10.122

5.  Increased arachidonic acid incorporation into platelet phospholipids in type 2 (non-insulin-dependent) diabetes.

Authors:  R Takahashi; I Morita; Y Saito; H Ito; S Murota
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

6.  Inhibition of human platelet functions by cyclandelate.

Authors:  W E van den Hoven; D W Hall
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Prostacyclin and thromboxane in diabetes.

Authors:  O Ylikorkala; J Kaila; L Viinikka
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-31

8.  Network reconstruction of platelet metabolism identifies metabolic signature for aspirin resistance.

Authors:  Alex Thomas; Sorena Rahmanian; Aarash Bordbar; Bernhard Ø Palsson; Neema Jamshidi
Journal:  Sci Rep       Date:  2014-01-29       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.